Cardiovascular and inflammatory effects of intratracheally instilled ambient dust from Augsburg, Germany, in spontaneously hypertensive rats (SHRs)

Particle and Fibre Toxicology

Volumn 7, Issue , 2010, Pages

  Upadhyay, Swapna ^a   Ganguly, Koustav ^a   Stoeger, Tobias ^a   Semmler Bhenke, Manuela ^a   Takenaka, Shinji ^a   Kreyling, Wolfgang G ^a,b   Pitz, Mike ^a   Reitmeir, Peter ^a,b   Peters, Annette ^a   Eickelberg, Oliver ^a   Wichmann, H Erich ^a,b   Schulz, Holger ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b German Research Center for Environmental Health ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; OSTEOPONTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN;

AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DUST EXPOSURE; GERMANY; HEART RATE VARIABILITY; HISTOPATHOLOGY; INFLAMMATION; LUNG LAVAGE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; ACUTE PHASE RESPONSE; ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECT; DUST; HEART; HEART MUSCLE; HEART RATE; HOMEOSTASIS; INTRASPINAL DRUG ADMINISTRATION; LUNG; MALE; PATHOLOGY;

RATTUS;

ACUTE-PHASE REACTION; ANIMALS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DUST; GERMANY; HEART; HEART RATE; HOMEOSTASIS; INFLAMMATION; INJECTIONS, SPINAL; LUNG; MALE; MYOCARDIUM; PARTICULATE MATTER; RATS; RATS, INBRED SHR;

EID: 77957148034     PISSN: 17438977     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-8977-7-27     Document Type: Article

References (86)

1. WHO The World Health Report. Reducing Risks, Promoting Healthy Life. 2002, Geneva, Switzerland: World Health Organisation, WHO.
2. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An association between air pollution and mortality in six US cities. N Engl J Med 1993, 329:1753-1759. 10.1056/NEJM199312093292401, 8179653.
3. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 US cities1987-1994. N Engl J Med 2000, 343:1742-1749. 10.1056/NEJM200012143432401, 11114312.
4. Pope CA, Muhlestein JB, May HT, Renlund DG, Anderson JL, Horne BD. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation 2006, 114(23):2443-2448. 10.1161/CIRCULATIONAHA.106.636977, 17101851.
5. Peters A, von Klot S, Heier M, Trentinaglia I, Cyrys J, Hörmann A, Hauptmann M, Wichmann HE, Löwel H. Particulate air pollution and nonfatal cardiac events. Part I. Air pollution, personal activities, and onset of myocardial infarction in a case-crossover study. Res Rep Health Eff Inst 2005, (124):1-66. discussion 67-82, 141-148.
6. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287:1132-1141. 10.1001/jama.287.9.1132, 11879110.
7. Sandhu RS, Petroni DH, George WJ. Ambient particulate matter, C-reactive protein, and coronary artery disease. Inhal Toxicol 2005, 17:409-413. 10.1080/08958370590929538, 16020037.
8. Dockery DW, Luttmann-Gibson H, Rich DQ, Link MS, Mittleman MA, Gold DR, Koutrakis P, Schwartz JD, Verrier RL. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect 2005, 113(6):670-4. 10.1289/ehp.7767, 1257589, 15929887.
9. Peters A, Perz S, Dö ring A, Stieber J, Koenig W, Wichmann H-E. Increases in heart rate during an air pollution episode. Am J Epidemiol 1999, 150:1094-8.
10. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001, 103:2810-2815.
11. von Klot S, Peters A, Aalto P, Bellander T, Berglind N, D'Ippoliti D, Elosua R, Hörmann A, Kulmala M, Lanki T, Löwel H, Pekkanen J, Picciotto S, Sunyer J, Forastiere F. Ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in five European cities. Circulation 2005, 112:3073-3079. 10.1161/CIRCULATIONAHA.105.548743, 16286602.
12. Zanobetti A, Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect 2005, 113:978-982. 10.1289/ehp.7550, 1280336, 16079066.
13. André E, Stoeger T, Takenaka S, Bahnweg M, Ritter B, Karg E, Lentner B, Reinhard C, Schulz H, Wjst M. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur Respir J 2006, 28(2):275-85. Epub 2006 Apr 26, 10.1183/09031936.06.00071205, 16641123.
14. Stenfors N, Nordenhall C, Salvi SS, Mudway I, Soderberg M, Blomberg A, Helleday R, Levin JO, Holgate ST, Kelly FJ, Frew AJ, Sandstrom T. Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J 2004, 23:82-86. 10.1183/09031936.03.00004603, 14738236.
15. Schulz H, Harder V, Ibald-Mulli A, Khandoga A, Koenig W, Krombach F, Radykewicz R, Stampfl A, Thorand B, Peters A. Cardiovascular effects of fine and ultrafine particles. J Aerosol Med 2005, 18:1-22. 10.1089/jam.2005.18.1, 15741770.
16. Salvi S, Holgate ST. Mechanisms of particulate matter toxicity. Clin Exp Allergy 1999, 29:1187-1194. 10.1046/j.1365-2222.1999.00576.x, 10469026.
17. Peters A, Döring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality?. Lancet 1997, 349:1582-1587. 10.1016/S0140-6736(97)01211-7, 9174559.
18. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health effects. Lancet 1995, 345:176-178. 10.1016/S0140-6736(95)90173-6, 7741860.
19. Nurkiewicz TR, Porter DW, Barger M, Castranova V, Boegehold MA. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect 2004, 112(13):1299-1306. 10.1289/ehp.7001, 1247520, 15345343.
20. Peters A, Fröhlich M, Döring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys MB, Koenig W. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 2001, 22(14):1198-204. 10.1053/euhj.2000.2483, 11440492.
21. Verrier RL, Mittleman MA, Stone PH. Air pollution: an insidious and pervasive component of cardiac risk. Circulation 2002, 106:890-892. 10.1161/01.CIR.0000027434.34445.23, 12186787.
22. de Leeuw FAAM, van Rheineck Leyssius HJ. Long-range transport modelling of air pollution episodes. Environ Health Perspect 1989, 79:53-59. 10.2307/3430529, 1567598, 2707211.
23. Wichmann HE, Mueller W, Allhoff P, Beckmann M, Bocter N, Csicsaky MJ, Jung M, Molik B, Schoeneberg G. Health Effects During a Smog Episode in West Germany in 1985. Environ Health Perspect 1989, 79:89-99. 10.2307/3430534, 1567592, 2495934.
24. Keil U, Stieber J, Döring A, Chambless L, Härtel U, Filipiak B, Hense HW, Tietze M, Gostomzyk JG. The cardiovascular risk factor profile in the study area Augsburg: Results from the first MONICA survey 1984/85. Acta Med Scand 1988, 728:119-128.
25. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health 2001, 1(4):571-7.
26. Peters A, von Klot S, Heier M, Trentinaglia I, Hörmann A, Wichmann HE, Löwel H. Exposure to traffic and the onset of myocardial infarction. N Engl J Med 2004, 351(17):1721-1730. 10.1056/NEJMoa040203, 15496621.
27. Bikhazi AB, Saadeh FA, Haddad RE, Nahle ZA, Abou Fares MF, Bitar KM, Birbari AE. Insulin-receptor binding characteristics in perfused SHR and WKY rat hearts. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998, 120(1):127-136. 10.1016/S0742-8413(98)00033-4, 9827025.
28. Sebkhi A, Zhao L, Lu L, Haley CS, Nunez DJ, Wilkins MR. Genetic determination of cardiac mass in normotensive rats: results from an F344xWKY cross. Hypertension 1999, 33(4):949-953.
29. Kodavanti UP, Schladweiler MC, Ledbetter AD, Ortuno RV, Suffia M, Evansky P, Richards JH, Jaskot RH, Thomas R, Karoly E, Huang YC, Costa DL, Gilmour PS, Pinkerton KE. The spontaneously hypertensive rat: an experimental model of sulfur dioxide-induced airways disease. Toxicol Sci 2006, 94(1):193-205. 10.1093/toxsci/kfl087, 16929007.
30. Mangum JB, Bermudez E, Sar M, Everitt JI. Osteopontin expression in particle-induced lung disease. 2004, 30(7):585-598.
31. Kodavanti UP, Schladweiler MC, Ledbetter AD, Watkinson WP, Campen MJ, Winsett DW, Richards JR, Crissman KM, Hatch GE, Costa DL. The spontaneously hypertensive rat as a model of human cardiovascular disease: evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter. Toxicol Appl Pharmacol 2000, 164(3):250-63. 10.1006/taap.2000.8899, 10799335.
32. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Whitsel L, Kaufman JD. Particulate Matter Air Pollution and Cardiovascular Disease. An Update to the Scientific Statement From the American Heart Association. Circulation 2010,
33. Nogueira JB. Air pollution and cardiovascular disease. Rev Port Cardiol 2009, 28(6):715-733.
34. Peters A, Schneider A, Greven S, Bellander T, Forastiere F, Ibald-Mulli A, Illig T, Jacquemin B, Katsouyanni K, Koenig W, Lanki T, Pekkanen J, Pershagen G, Picciotto S, Rückerl R, Rosario AS, Stefanadis C, Sunyer J. Air pollution and inflammatory response in myocardial infarction survivors: gene-environment interactions in a high-risk group. Inhal Toxicol 2007, 19:161-175. 10.1080/08958370701496129, 17886064.
35. Nemmar A, Hoet PH, Vermylen J, Nemery B, Hoylaerts MF. Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters. Circulation 2004, 110(12):1670-1677. 10.1161/01.CIR.0000142053.13921.21, 15364808.
36. Gerlofs-Nijland ME, Boere AJ, Leseman DL, Dormans JA, Sandström T, Salonen RO, van Bree L, Cassee FR. Effects of particulate matter on the pulmonary and vascular system: time course in spontaneously hypertensive rats. Part Fibre Toxicol 2005, 2(1):2.. 10.1186/1743-8977-2-2, 1079943, 15813961.
37. Cyrys J, Pitz M, Heinrich J, Wichmann HE, Peters A. Spatial and temporal variation of particle number concentration in Augsburg, Germany. Science of the Total Environment 2008, 401(1-3):168-175. 10.1016/j.scitotenv.2008.03.043, 2583026, 18511107.
38. Pitz M, Birmili W, Schmid O, Peters A, Wichmann HE, Cyrys J. Quality control and quality assurance for particle size distribution measurements at an urban monitoring station in Augsburg, Germany. Journal of Environmental Monitoring 2008, 10(9):1017-1024. 10.1039/b807264g, 18728893.
39. Pitz M, Schmid O, Heinrich J, Birmili W, Maguhn J, Zimmermann R, Wichmann HE, Peters A, Cyrys J. Seasonal and diurnal variation of PM2.5 apparent particle density in urban air in Augsburg, Germany. Environmental Science and Technology 2008, 42(14):5087-5093. 10.1021/es7028735, 18754352.
40. Sklorz M, Schnelle-Kreis J, Liu Y, Orasche J, Zimmermann R. Daytime resolved analysis of polycyclic aromatic hydrocarbons in urban aerosol samples - impact of sources and meteorological conditions. Chemosphere 2007, 67(5):934-943. 10.1016/j.chemosphere.2006.11.006, 17182082.
41. Sklorz M, Briedé JJ, Schnelle-Kreis J, Liu Y, Cyrys J, de Kok TM, Zimmermann R. Concentration of oxygenated polycyclic aromatic hydrocarbons and oxygen free radical formation from urban particulate matter. J Toxicol Environ Health A 2007, 70(21):1866-1869. 10.1080/15287390701457654, 17934959.
42. Schnelle-Kreis J, Sklorz M, Orasche J, Stölzel M, Peters A, Zimmermann R. Semii volatile organic compounds in ambient PM2.5. Seasonal trends and daily resolved source contributions. Environ Sci Technol 2007, 41(11):3821-3828. 10.1021/es060666e, 17612155.
43. Schnelle-Kreis J, Küpper U, Sklorz M, Cyrys J, Briedé JJ, Peters A, Zimmermann R. Daily measurement of organic compounds in ambient particulate matter in Augsburg, Germany: new aspects on aerosol sources and aerosol related health effects. Biomarkers 2009, 14(1):39-44. 10.1080/13547500902965997, 19604057.
44. Elder A, Couderc JP, Gelein R, Eberly S, Cox C, Xia X, Zareba W, Hopke P, Watts W, Kittelson D, Frampton M, Utell M, Oberdörster G. Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol 2007, 19(1):1-12. 10.1080/08958370600985735, 17127638.
45. Upadhyay S, Stoeger T, Harder V, Thomas RF, Schladweiler MC, Semmler-Behnke M, Takenaka S, Karg E, Reitmeir P, Bader M, Stampfl A, Kodavanti UP, Schulz H. Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats. Part Fibre Toxicol 2008, 5:19. 10.1186/1743-8977-5-19, 2612692, 19055790.
46. Campen MJ, Nolan JP, Schladweiler MC, Kodavanti UP, Costa DL, Watkinson WP. Cardiac and thermoregulatory effects of instilled particulate matter-associated transition metals in healthy and cardiopulmonary-compromised rats. J Toxicol Environ Health A 2002, 65(20):1615-1631. 10.1080/00984100290071694, 12396871.
47. Wichers LB, Nolan JP, Winsett DW, Ledbetter AD, Kodavanti UP, Schladweiler MC, Costa DL, Watkinson WP. Effects of instilled combustion-derived particles in spontaneously hypertensive rats. Part II: Pulmonary responses. Inhal Toxicol 2004, 16(6-7):407-419. 10.1080/08958370490439704, 15204756.
48. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005, 113(11):1555-1560. 10.1289/ehp.8006, 1310918, 16263511.
49. Kreyling WG, Möller W, Semmler-Behnke M, Obersdörster G. Particle Dosimetry: Deposition and clearance from the Respiratory Tract and Translocation Towards Extra-Pulmonary Sites. Particle Toxicology 2007, 48-69. New York: CRC Press/Taylor & Francis, Donaldson K, Borm P.
50. O'Regan A. The Role of osteopontin in lung disease. Cytokine & Growth Factor Reviews 2003, 14(6):479-488.
51. Rückerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T, Berglind N, Chrysohoou C, Forastiere F, Jacquemin B, von Klot S, Koenig W, Küchenhoff H, Lanki T, Pekkanen J, Perucci CA, Schneider A, Sunyer J, Peters A. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007, 115(7):1072-1080. 10.1289/ehp.10021, 1913563, 17637925.
52. Lei YC, Chen MC, Chan CC, Wang PY, Lee CT, Cheng TJ. Effects of concentrated ambient particles on airway responsiveness and pulmonary inflammation in pulmonary hypertensive rats. Inhal Toxicol 2004, 16(11-12):785-792. 10.1080/08958370490490572, 16036748.
53. Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J, Watt M, Agius R, Stout R. Particulate air pollution and the blood. Thorax 1999, 54(11):1027-1032. 10.1136/thx.54.11.1027, 1745387, 10525563.
54. Polichetti G, Cocco S, Spinali A, Trimarco V, Nunziata A. Effects of particulate matter (PM(10), PM(2.5) and PM(1)) on the cardiovascular system. Toxicology 2009, 261(1-2):1-8. 10.1016/j.tox.2009.04.035, 19379789.
55. Zhao J, Xie Y, Qian X, Jiang R, Song W. Acute effects of fine particles on cardiovascular system: differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol Lett 193(1):50-60. 10.1016/j.toxlet.2009.12.002, 20025942.
56. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, Sandström T, Blomberg A, Newby DE. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009, 6(1):36-44. 10.1038/ncpcardio1399, 19029991.
57. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979. 10.1056/NEJM199704033361401, 9077376.
58. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107(3):363-369. 10.1161/01.CIR.0000053730.47739.3C, 12551853.
59. Driscoll KE, Hassenbein DG, Carter JM, Kunkel SL, Quinlan TR, Mossman BT. TNF alpha and increased chemokine expression in rat lung after particle exposure. Toxicol Lett 1995, 82-83. 483-489.
60. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med 2003, 168(11):1366-1372. 10.1164/rccm.200306-801OC, 12969870.
61. Kodavanti UP, Schladweiler MC, Ledbetter AD, Hauser R, Christiani DC, McGee J, Richards JR, Costa DL. Temporal association between pulmonary and systemic effects of particulate matter in healthy and cardiovascular compromised rats. J Toxicol Environ Health A 2002, 65(20):1545-1569. 10.1080/00984100290071667, 12396868.
62. Kodavanti UP, Schladweiler MC, Gilmour PS, Wallenborn JG, Mandavilli BS, Ledbetter AD, Christiani DC, Runge MS, Karoly ED, Costa DL, Peddada S, Jaskot R, Richards JH, Thomas R, Madamanchi NR, Nyska A. The role of particulate matter-associated zinc in cardiac injury in rats. Environ Health Perspect 2008, 116(1):13-20. 10.1289/ehp.10379, 2199289, 18197293.
63. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 2006, 114(3):328-33. 10.1289/ehp.8266, 1392224, 16507453.
64. Wallenborn JG, Schladweiler MJ, Richards JH, Kodavanti UP. Differential pulmonary and cardiac effects of pulmonary exposure to a panel of particulate matter-associated metals. Toxicol Appl Pharmacol 2009, 241(1):71-80. 10.1016/j.taap.2009.08.003, 19679144.
65. Bagate K, Meiring JJ, Gerlofs-Nijland ME, Cassee FR, Borm PJ. Signal transduction pathways involved in particulate matter induced relaxation in rat aorta--spontaneous hypertensive versus Wistar Kyoto rats. Toxicol In Vitro 2006, 20(1):52-62. 10.1016/j.tiv.2005.06.002, 16055302.
66. Wedgwood S, Black SM. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 2003, 5(6):759-769. 10.1089/152308603770380061, 14588149.
67. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002, 106:2372-2378. 10.1161/01.CIR.0000033972.90653.AF, 12403669.
68. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992, 89(15):6998-7002. 10.1073/pnas.89.15.6998, 49632, 1495992.
69. Youming P, Hong L, Fuyou L, Lin O, Meichu C, Lei G, Fulin P, Yinghong L, Xing C, Jun L. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients. Nephrology 2008, 13(7):579-586. (8), 10.1111/j.1440-1797.2008.00987.x, 19161364.
70. Lahm T, Crisostomo PR, Markel TA, Wang M, Lillemoe KD, Meldrum DR. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 2007, 28(1):4-14. 10.1097/shk.0b013e31804d1998, 17510598.
71. Tuder RM, Flook BE, Voelkel NF. Increased Gene Expression for VEGF and the VEGF Receptors KDRIFIk and Fit in Lungs Exposed to Acute or to Chronic Hypoxia Modulation of Gene Expression by Nitric Oxide. J Clin Invest 1995, 95:1798-1807. 10.1172/JCI117858, 295709, 7706486.
72. Campbell Andrew IM, Yidan Z, Reena S, Duncan J S. Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension. Circulation 2001, 104:2242-2248. 10.1161/hc4201.097838, 11684638.
73. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107(10):1255-1262. 10.1172/JCI11871, 209298, 11375415.
74. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993, 171(3):223-229. 10.1002/path.1711710311, 7506307.
75. Hanyu M, Kume N, Ikeda T, Minami M, Kita T, Komeda M. VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits--a potential role in vein graft atherosclerosis. Atherosclerosis 2001, 158(2):313-319. 10.1016/S0021-9150(01)00446-4, 11583709.
76. Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(1):44-49. 10.1513/pats.200410-050SF, 16113468.
77. Karoly ED, Li Z, Dailey LA, Hyseni X, Huang YC. Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure. Environ Health Perspect 2007, 115:535-540. 10.1289/ehp.9556, 1852686, 17450221.
78. Gilmour PS, Nyska A, Schladweiler MC, McGee JK, Wallenborn JG, Richards JH, Kodavanti UP. Cardiovascular and blood coagulative effects of pulmonary zinc exposure. J Toxicol Appl Pharmacol 2006, 211:41-52.
79. Poli KA, Tofler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I, Mittleman MA, Muller JE, D'Agostino RB, Wilson PW, Levy D. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000, 101:264-269.
80. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004, 61(1):159-168. 10.1016/j.cardiores.2003.10.019, 14732213.
81. Kanno K, Hirata Y, Tsujino M, Imai T, Shichiri M, Ito H, Marumo F. Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun 1993, 194(3):1282-1287. 10.1006/bbrc.1993.1962, 8352786.
82. Gerlofs-Nijland ME, Rummelhard M, Boere AJ, Leseman DL, Duffin R, Schins RP, Borm PJ, Sillanpää M, Salonen RO, Cassee FR. Particle induced toxicity in relation to transition metal and polycyclic aromatic hydrocarbon contents. Environ Sci Technol 2009, 43(13):4729-4736. 10.1021/es803176k, 19673258.
83. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, Mac-Nee W, Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005, 2(10).
84. Happo MS, Salonen RO, Hälinen AI, Jalava PI, Pennanen AS, Dormans JA, Gerlofs-Nijland ME, Cassee FR, Kosma VM, Sillanpää M, Hillamo R, Hirvonen MR. Inflammation and tissue damage in mouse lung by single and repeated dosing of urban air coarse and fine particles collected from six European cities. Inhal Toxicol 2010, 22(5):402-416. 10.3109/08958370903527908, 20121583.
85. Brown RH, Walters DM, Greenberg RS, Mitzner W. A method of endotracheal intubation and pulmonary functional assessment for repeated studies in mice. J Appl Physiol 1999, 87(6):2362-2365.
86. Harder V, Gilmour P, Lentner B, Karg E, Takenaka S, Ziesenis A, Stampfl A, Kodavanti U, Heyder J, Schulz H. Cardiovascular responses in unrestrained WKY rats to inhaled ultrafine carbon particles. Inhal Toxicol 2005, 17(1):29-42. 10.1080/08958370590885681, 15764481.